Skip to menu Skip to content Skip to footer
Dr

Emily Strong

Email: 

Overview

Availability

Dr Emily Strong is:
Available for supervision

Qualifications

  • Doctor of Philosophy, unknown

Works

Search Professor Emily Strong’s works on UQ eSpace

14 works between 2016 and 2024

1 - 14 of 14 works

2024

Journal Article

Identification of Axinellamines A and B as Anti-Tubercular Agents

Strong, Emily J., Tan, Lendl, Hayes, Sasha, Whyte, Hayden, Davis, Rohan A. and West, Nicholas P. (2024). Identification of Axinellamines A and B as Anti-Tubercular Agents. Marine Drugs, 22 (7) 298, 298. doi: 10.3390/md22070298

Identification of Axinellamines A and B as Anti-Tubercular Agents

2024

Journal Article

Reassessing the putative molecular Target(s) of potent antitubercular 2-(Alkylsulfonyl)acetamides

Farr, Dylan C., Haselhorst, Thomas, Tan, Lendl, Furness, Juanelle, Strong, Emily, Grice, I. Darren, West, Nicholas P. and Houston, Todd A. (2024). Reassessing the putative molecular Target(s) of potent antitubercular 2-(Alkylsulfonyl)acetamides. European Journal of Medicinal Chemistry, 264 115983, 1-12. doi: 10.1016/j.ejmech.2023.115983

Reassessing the putative molecular Target(s) of potent antitubercular 2-(Alkylsulfonyl)acetamides

2023

Conference Publication

Macrophage plasticity and activation states drive differential expression of murine macrophage galactose-type lectin (MGL) orthologs

Paez, Reina N., Browning, Sarah, Files, Megan A., Varghese, Alyssa A., Huante, Matthew B., Strong, Emily, Lee, Sunhee, Endsley, Mark A. and Endsley, Janice J. (2023). Macrophage plasticity and activation states drive differential expression of murine macrophage galactose-type lectin (MGL) orthologs. Annual Meeting of the American Association of Immunologists (AAI), Washington, DC United States, 11-15 May 2023. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.210.Supp.160.32

Macrophage plasticity and activation states drive differential expression of murine macrophage galactose-type lectin (MGL) orthologs

2022

Journal Article

FDA-approved amoxapine effectively promotes macrophage control of mycobacteria by inducing autophagy

Wang, Jia, Sha, Jian, Strong, Emily, Chopra, Ashok K. and Lee, Sunhee (2022). FDA-approved amoxapine effectively promotes macrophage control of mycobacteria by inducing autophagy. Microbiology Spectrum, 10 (5). doi: 10.1128/spectrum.02509-22

FDA-approved amoxapine effectively promotes macrophage control of mycobacteria by inducing autophagy

2022

Journal Article

Reversing BCG-mediated autophagy inhibition and mycobacterial survival to improve vaccine efficacy

Gonzalez-Orozco, Maria, Strong, Emily J., Paroha, Ruchi and Lee, Sunhee (2022). Reversing BCG-mediated autophagy inhibition and mycobacterial survival to improve vaccine efficacy. BMC Immunology, 23 (1) 43. doi: 10.1186/s12865-022-00518-z

Reversing BCG-mediated autophagy inhibition and mycobacterial survival to improve vaccine efficacy

2022

Journal Article

Mycobacterium tuberculosis PPE51 inhibits autophagy by suppressing toll-like receptor 2-dependent signaling

Strong, Emily J., Wang, Jia, Ng, Tony W., Porcelli, Steven A. and Lee, Sunhee (2022). Mycobacterium tuberculosis PPE51 inhibits autophagy by suppressing toll-like receptor 2-dependent signaling. MBio, 13 (3). doi: 10.1128/mbio.02974-21

Mycobacterium tuberculosis PPE51 inhibits autophagy by suppressing toll-like receptor 2-dependent signaling

2022

Journal Article

Induced synthesis of mycolactone restores the pathogenesis of Mycobacterium ulcerans in vitro and in vivo

Strong, Emily, Hart, Bryan, Wang, Jia, Orozco, Maria Gonzalez and Lee, Sunhee (2022). Induced synthesis of mycolactone restores the pathogenesis of Mycobacterium ulcerans in vitro and in vivo. Frontiers in Immunology, 13 750643. doi: 10.3389/fimmu.2022.750643

Induced synthesis of mycolactone restores the pathogenesis of Mycobacterium ulcerans in vitro and in vivo

2021

Journal Article

Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 proteins inhibit autophagy by interaction with Rab1A

Strong, Emily J., Ng, Tony W., Porcelli, Steven A. and Lee, Sunhee (2021). Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 proteins inhibit autophagy by interaction with Rab1A. Msphere, 6 (4), 1-17. doi: 10.1128/msphere.00549-21

Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 proteins inhibit autophagy by interaction with Rab1A

2021

Journal Article

Targeting autophagy as a strategy for developing new vaccines and host-directed therapeutics against mycobacteria

Strong, Emily J. and Lee, Sunhee (2021). Targeting autophagy as a strategy for developing new vaccines and host-directed therapeutics against mycobacteria. Frontiers in Microbiology, 11 614313. doi: 10.3389/fmicb.2020.614313

Targeting autophagy as a strategy for developing new vaccines and host-directed therapeutics against mycobacteria

2020

Journal Article

Identification of autophagy-inhibiting factors of mycobacterium tuberculosis by high-throughput loss-of-function screening

Strong, Emily J., Jurcic Smith, Kristen L., Saini, Neeraj K., Ng, Tony W., Porcelli, Steven A. and Lee, Sunhee (2020). Identification of autophagy-inhibiting factors of mycobacterium tuberculosis by high-throughput loss-of-function screening. Infection and Immunity, 88 (12) e00269-20. doi: 10.1128/IAI.00269-20

Identification of autophagy-inhibiting factors of mycobacterium tuberculosis by high-throughput loss-of-function screening

2018

Journal Article

Homologous alignment cloning: a rapid, flexible and highly efficient general molecular cloning method

Tan, Lendl, Strong, Emily J., Woods, Kyra and West, Nicholas P. (2018). Homologous alignment cloning: a rapid, flexible and highly efficient general molecular cloning method. PeerJ, 6 (6) e5146, e5146. doi: 10.7717/peerj.5146

Homologous alignment cloning: a rapid, flexible and highly efficient general molecular cloning method

2018

Journal Article

Use of soluble extracellular regions of MmpL (SERoM) as vaccines for tuberculosis

Strong, Emily J. and West, Nicholas P. (2018). Use of soluble extracellular regions of MmpL (SERoM) as vaccines for tuberculosis. Scientific Reports, 8 (1) 5604, 5604. doi: 10.1038/s41598-018-23893-3

Use of soluble extracellular regions of MmpL (SERoM) as vaccines for tuberculosis

2017

Other Outputs

A Functional Genomics Approach to Vaccine Development Against Mycobacterium tuberculosis and the Role MmpL13 Plays in Tuberculosis Infection

Strong, Emily (2017). A Functional Genomics Approach to Vaccine Development Against Mycobacterium tuberculosis and the Role MmpL13 Plays in Tuberculosis Infection. PhD Thesis, School of Chemistry & Molecular Biosciences, The University of Queensland. doi: 10.14264/uql.2017.1037

A Functional Genomics Approach to Vaccine Development Against Mycobacterium tuberculosis and the Role MmpL13 Plays in Tuberculosis Infection

2016

Journal Article

Burkholderia pseudomallei capsule exacerbates respiratory melioidosis but does not afford protection against antimicrobial signaling or bacterial killing in human olfactory ensheathing cells

Dando, Samantha J., Ipe, Deepak S., Batzloff, Michael, Sullivan, Matthew J., Crossman, David K., Crowley, Michael, Strong, Emily, Kyan, Stephanie, Leclercq, Sophie Y., Ekberg, Jenny A. K., St John, James, Beacham, Ifor R. and Ulett, Glen C. (2016). Burkholderia pseudomallei capsule exacerbates respiratory melioidosis but does not afford protection against antimicrobial signaling or bacterial killing in human olfactory ensheathing cells. Infection and Immunity, 84 (7), 1941-1956. doi: 10.1128/IAI.01546-15

Burkholderia pseudomallei capsule exacerbates respiratory melioidosis but does not afford protection against antimicrobial signaling or bacterial killing in human olfactory ensheathing cells

Funding

Current funding

  • 2023 - 2027
    A Faster Cure for Tuberculosis: Revealing Adjunctive Antimicrobial Solutions
    NHMRC IDEAS Grants
    Open grant

Supervision

Availability

Dr Emily Strong is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Boosting BCG: The use of Potent Immunostimulatory Secreted Antigens of Mycobacterium tuberculosis.

    Associate Advisor

    Other advisors: Associate Professor Nick West

Media

Enquiries

For media enquiries about Dr Emily Strong's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au